SS

Shilpa Sanjay Sanghavi

Active Director Director DIN 01957381
DIN 01957381 First appointment Sep 2009 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Current companies 10 active board seats
Past companies 4 historical roles
Total affiliations 14 Since Sep 2009
Shareholding value •••• Premium profile

About Shilpa Sanjay Sanghavi

Data last updated:

Shilpa Sanjay Sanghavi is a Director at Sumo Medexim Limited (since 2012), Director at Hetwi Trading Private Limited (since 2024) and Partner at Dhanush Leasing And Finance Llp (since 2015), and holds 7 more current directorships. The companies operate in Financial Services, Agriculture and Manufacturing. The largest current company by reported revenue is Sumo Medexim Limited at ₹36.2 Lakh (FY 2025). Earlier, Shilpa Sanjay Sanghavi was a Director at Maple Metchem Private Limited (from 2009) and Director at Bulltext Infrastructure Private Limited (from 2013) and 2 more.

DIN 01957381
Primary Designation Director
Industry Financial Services
First Appointment 15 Sep 2009
Oldest Company Age 31 yrs
Largest company Sumo Medexim Limited · ₹36.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sumo Medexim Limited U24239MH1995PLC088349
Director31 Jan 20121995₹36.2 Lakh (FY 2025)Active
Hetwi Trading Private Limited U51109WB2005PTC105914
Director01 Apr 20242005Active
Partner01 Apr 20152015Active
Designated Partner01 Apr 20152015Active
Designated Partner27 Mar 20152015Active
Designated Partner18 Mar 20152015Active
Designated Partner18 Mar 20152015Active
Designated Partner18 Mar 20152015Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Maple Metchem Private Limited U27200MH2006PTC159384
Director15 Sep 20092006Converted To Llp
Director24 Jul 20132010Converted To Llp
Director24 Jul 20132010Converted To Llp
Premier Viniyog Private Limited U74990MH2009PTC189876
Director02 Feb 20122009Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Shilpa Sanjay Sanghavi

Directorship timeline

Open interactive timeline →
Sumo Medexim Limited
Maple Metchem Private Limited
Bulltext Infrastructure Private Limited
Bestworth Infrastructure Private Limited
Premium access

Shareholding and investment profile for Shilpa Sanjay Sanghavi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shilpa Sanjay Sanghavi

Shilpa Sanjay Sanghavi currently holds 10 directorships: Sumo Medexim Limited (Director, since 31 Jan 2012, revenue ₹36.2 Lakh (FY 2025)); Hetwi Trading Private Limited (Director, since 01 Apr 2024); Dhanush Leasing And Finance Llp (Partner, since 01 Apr 2015); Star Bio Source Llp (Designated Partner, since 01 Apr 2015); Kirti Shah Securities Llp (Designated Partner, since 27 Mar 2015); and 5 more.

Shilpa Sanjay Sanghavi was first appointed on 15 Sep 2009 as Director at Maple Metchem Private Limited. The most recent appointment on record is 01 Apr 2024 at Hetwi Trading Private Limited.

Shilpa Sanjay Sanghavi held 4 earlier board appointments: Maple Metchem Private Limited (Director, from 15 Sep 2009); Bulltext Infrastructure Private Limited (Director, from 24 Jul 2013); Bestworth Infrastructure Private Limited (Director, from 24 Jul 2013); Premier Viniyog Private Limited (Director, from 02 Feb 2012).

The current boards of Shilpa Sanjay Sanghavi's companies include Het Sanjay Sanghavi (Sumo Medexim Limited), Sanjay Manharlal Sanghavi (Sumo Medexim Limited), Manherlal Vanecnand Sanghavi (Dhanush Leasing And Finance Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available